Clinical Trials Browser

Active not recruiting × Meningeal Carcinomatosis × 90 days × Clear all

NCT04661384 2026-03-05

Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma

Phase 1 Active not recruiting

Ependymoma, Glioblastoma, Medulloblastoma, Meningeal Carcinomatosis